Top row (left to right): B. Hanna, J. Joers, P. Pisharady, K. France, P.G. Henry (PI), D. Deelchand, Y.W. Park. I. Adanyeguh (insert). Bottom row: D. Hutter, C. Lenglet (PI), G. Oz (PI), K. Gundry, J. Chandrasekaran. (not pictured - Shannon Smith)
(Names of people working directly on Friedreich Ataxia, including TRACK-FA, in blue)

What we do: The CMRR ataxia research team specializes in the development and use of cutting-edge magnetic resonance imaging (MRI) techniques to study how diseases affect the brain and spinal cord. We use various imaging techniques to study how the structure, chemistry and connectivity change in the nervous system at different stages of disease. That type of information is important for clinical trials, because it provides “biomarkers” which can detect and track small changes in the brain and spinal cord, sometimes even before symptoms start.

Why we are part of TRACK-FA: We are excited and proud to be part of the TRACK-FA consortium because this is the first large-scale multi-site natural history neuroimaging study in Friedreich ataxia. The UMN team oversees and coordinates the imaging part of TRACK-FA. This study will provide critical data on disease progression in more than 200 participants with FA and more than 100 controls. These data will serve as a “benchmark” to assess the effect of potential treatments in future clinical trials. Beyond science and the search for a cure, we are also very grateful for the chance to meet with participants FA and their families.

More info here:

Read a Special Interview with the Team